Global Cellulite Treatment Market - 2022-2029
本報告提供全球橘皮組織治療的市場調查，彙整市場定義和概要，新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素的分析，法律制度，未滿足需求，市場規模的轉變·預測，各種區分·地區/各主要國家的明細，競爭環境，主要企業簡介等資訊。
The global cellulite treatment market is estimated to reach a CAGR of 9.2 % during the forecast period (2022-2029).
Cellulite is a benign skin condition that causes lumpy, dimpled skin on the thighs, hips, buttocks, and abdomen. Women are the ones who are most affected.
The factors influencing the global cellulite treatment market are the increasing demand for cellulite treatment and the growing prevalence of cellulite.
The increasing demand for the treatment of cellulite is expected to drive the market growth
Connective tissue bands pull the skin overlying certain areas of fat downward to the deeper tissues, causing cellulite. As a result, the surface becomes uneven. Due to differences in fat, muscle, and connective tissue distribution, cellulite affects women more than men. It is estimated that 80 to 90 percent of women are affected somehow. Cellulite isn't dangerous.
Topical treatments may help reduce the appearance of cellulite, but the results may not last. Creams are supposed to tighten the skin, making it look smoother and firmer. They also add moisture, which can help with cellulite appearance. Creams, on the other hand, do not remove cellulite. Instead, they make it appear less prominently. Fat cells can still be found beneath the skin. Caffeine is a common ingredient in cellulite creams. Caffeine acts as a diuretic and increases blood flow to the area. This can alter the fat's water content, potentially reducing the appearance of cellulite. By thickening the outer layer of skin, products containing 0.3 percent retinol may help reduce cellulite's appearance. Hence, with increasing demand, various treatment options are being introduced and expected to drive market growth.
Limitations associated with the treatment of cellulite are expected to hamper the market growth
CoolSculpting is a non-invasive procedure that does not require any cuts, anesthesia, or the insertion of any instruments into the body. In 2018, it was the most popular body sculpting procedure in the US. CoolScuplting is a fat-loss technique that targets fat in areas of the body that are more difficult to lose through diet and exercise. It has fewer side effects than traditional fat-reduction procedures like liposuction. However, while it is generally safe, it has some potential side effects. Some people experience soreness at the CoolSculpting treatment site, similar to what they might experience after a strenuous workout or a minor muscle injury. Others have complained of stinging, firmness, mild discoloration, swelling, and itching. The cost of the procedure is also too high. For instance, the average cost of CoolSculpting treatment is $2,000-4,000. However, areas requiring small applicators, such as the chin and jaw, can cost anywhere from $700 to 900 dollars.
COVID-19 Impact Analysis
The pandemic caused major disruptions in the cellulite treatment market. Lockdown restrictions in several economies around the world caused a halt to non-essential therapies and procedures and a significant drop in hospital and clinic visits. Furthermore, people's declining socioeconomic status significantly reduced their expenditures on beauty and aesthetics. However, with the lockdown restrictions nearly lifted and increased vaccination campaigns on the rise, cellulite treatment is expected to become more popular in the coming years.
Minimally Invasive procedure segment is expected to dominate the market growth
Cellfina is the most effective treatment for cellulite reduction and the appearance of smoother, more attractive skin. The FDA has approved this minimally invasive, effective technique for treating this skin condition. Furthermore, research has shown that this treatment can improve skin for three years. When fibrous bands put too much pressure on the skin, cellulite develops. Dimples and puckering are the results of this pressure. The cellulite reduction treatment improves appearance by breaking up the fibrous bands that cause the skin to look dimpled and uneven with a special device. Subcision is a technique that has been used to improve the appearance of scars and wrinkles.
The Cellfina is a highly precise instrument that gently releases the fibrous connective bands that pull the skin down and cause the visible dimpling. Cellfina targets cellulite and has been shown to smooth the skin in the treated area. The fibrous connective bands woven through the connective tissues of the upper legs and buttocks cause cellulite. There have been cellulite-fixing solutions for years, but they never address the root cause of cellulite.
North America region is expected to hold the largest market share in the global cellulite treatment market
An increase in the adoption of advanced technologies in the region and an increase in the number of obesity cases due to a sedentary lifestyle is expected to drive the market growth.
There has been a shift away from surgical procedures and toward non-invasive treatments in recent years. According to the 2018 Plastic Surgery Statistics, 5.8 million reconstructive procedures were performed globally in 2018, down from the previous two years, indicating that non-invasive treatments are driving the market in the region. Moreover, on 9th July 2020, Collagenase clostridium histolyticum-aaes (Qwo, Endo International) was approved by the US Food and Drug Administration (FDA) to treat moderate-to-severe cellulite in the buttocks in adults women, making it the first FDA-approved injectable cellulite treatment.
The global cellulite treatment market is moderately competitive with mergers, acquisitions, and product launches. Some of the key players in the market are Merz Pharma GmbH & Co KgaA, Inceler Medikal Co Ltd, Candela Corporation, Cynosure, Cutera Inc, Zimmer Aesthetics, Cymedics GmbH & Co KG, Beijing Nubway S&T Co Ltd, Endo Aesthetics LLC
Endo Aesthetics LLC
Overview: Endo Aesthetics is a research and development-driven company. Endo Aesthetics is advancing solutions to address unmet needs, starting with the first FDA-approved injectable treatment for buttock cellulite.
Product Portfolio: QWO is a prescription drug used to treat moderate to severe cellulite in adult women's buttocks.
The global cellulite treatment market report would provide an access to an approx. 45+market data table, 40+figures and 185 pages.
Key Development: On July 6, 2020, Endo International plc's Qwo (collagenase clostridium histolyticum-aaes) was approved by the US Food and Drug Administration (FDA) to treat moderate to severe cellulite in adult women's buttocks.
LIST NOT EXHAUSTIVE